Cedarburg Pharmaceuticals, A Division of AMRI

Cedarburg Pharmaceuticals, a division of Albany Molecular Research Inc. (AMRI), is located in Grafton, Wisconsin (U.S.A.). The Cedarburg Pharmaceuticals division specializes in the development and manufacturing of technically complex small molecule APIs for both clinical and commercial applications. Taking a drug substance from the bench to commercial manufacturing requires a unique skill set, and Cedarburg’s experienced team has provided API development and manufacturing for support for 13 FDA approved products and numerous clinical compounds. With GMP facilities capable of manufacturing APIs in quantities ranging from grams to hundreds of kilograms, Cedarburg Pharmaceuticals has manufacturing solutions for each stage of the pharmaceutical development cycle – from preclinical to commercial manufacturing.